Category: tools-profils-members

Independent Director Benoît Habert is Executive Vice President and Director of the Marcel Dassault Industrial Group and is a board member of several listed and private companies. He holds an MBA from INSEAD and a Master of Business Law. Benoît Habert has been a Director of the Company since 2000. Committees: member of the Compensation… Continue reading Benoît HABERT

Director Jean-Pierre Bizzari, MD, is a Doctor of Medicine, graduate of the Nice medical school and a specialist in oncology. He served as Executive Vice-President, Group Head, and Clinical Oncology Development (US, Europe, and Asia/Japan) at Celgene from 2008 to 2015. Prior to joining Celgene, he served as Vice President for Clinical Development Oncology at… Continue reading Dr. Jean-Pierre BIZZARI

Independent Director Antoine Béret was Chief Executive Officer (CEO) of Genoscience Pharma SAS and Chairman of Axenis. He graduated from École Nationale des Ponts et Chaussées and Ecole Polytechnique. Antoine Béret co-founded several companies specializing in biomedicine, including Trophos where he served as CEO until 2008 and Immunotech that he directed until 1996 when Immunotech… Continue reading Antoine BÉRET

Director, Chairman of the Strategy Committee Jean-Luc Bélingard was Chairman and Chief Executive Officer of bioMérieux S.A from 2010 to 2017. He graduated from the Ecole des Hautes Etudes Commerciales (HEC) of Paris (1971) and holds a Master of Business Administration (MBA) from Cornell University, US (1974). Since then, he has held management positions at… Continue reading Jean-Luc BÉLINGARD

Director Philippe Archinard, Ph.D. has been Executive Vice-President, Technological Innovation and Scientific Partnerships at Institut Mérieux since 2021. He was Chairman and Chief Executive Officer of Transgene from 2010 to 2020; and CEO from 2004 to 2020. Previously he was CEO of Innogenetics from 2000 to 2010. From 1985 to 2000, he held various positions… Continue reading Philippe ARCHINARD

VP, Human Resources Director Christelle SCHWOERER was appointed Director of Human Resources and joined the Executive Committee in April 2024. She joined Transgene’s Human Resources department in December 2013 as a Human Resources Assistant, after initial experience in construction and industry. Her various roles at Transgene have enabled her to develop generalist skills in human… Continue reading Gaëlle STADTLER

VP, General Counsel & Corporate Secretary John Felitti joined Transgene in March 2016 as General Counsel & Corporate Secretary. Before joining Transgene, he was Associate Vice President, Corporate Law, Finance & Securities Law at Sanofi and previously held other positions in the Sanofi and the Aventis legal departments. From 1996 to 2003, he was an… Continue reading John FELITTI

VP, Chief Business Officer James Wentworth, PhD, joined Transgene in 2024. Dr. Wentworth is responsible for developing, leading, and implementing Transgene’s business, corporate development and partnering strategies. He has over 15 years of experience working in the pharma and biotech industry.  James was Director, Business Development and Strategy at Adaptimmune, a NASDAQ-listed biotechnology company focused… Continue reading James Wentworth, PhD

VP, Chief Financial Officer (CFO) Since 2016, Lucie has served as Director Corporate Communications and Investor Relations, reporting to the CEO. Specialist in financial communications and press relations, Lucie came with over 10 years’ experience in communications agencies. She spent 3 years as a financial communications consultant at Ogilvy PR (2006 to 2008) before joining… Continue reading Lucie Larguier

VP Medical Affairs & Chief Medical Officer (CMO)  Maud Brandely joined Transgene as Chief Medical Officer in March 2016. Maud Brandely was previously Director of Clinical Development at Pierre Fabre Oncologie until February 2016. She was responsible for all clinical trials from Phase I to Phase III. As such, she was involved in the successful… Continue reading Maud BRANDELY